JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishimori, T.
Right arrow Articles by Konishi, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishimori, T.
Right arrow Articles by Konishi, J.
Journal of Nuclear Medicine Vol. 43 No. 5 658-663
© 2002 by Society of Nuclear Medicine


Basic Science Investigations

Increased 18F-FDG Uptake in a Model of Inflammation: Concanavalin A-Mediated Lymphocyte Activation

Takayoshi Ishimori, MD1, Tsuneo Saga, MD1, Marcelo Mamede, MD1, Hisataka Kobayashi, MD2, Tatsuya Higashi, MD1, Yuji Nakamoto, MD1, Noriko Sato, MD1 and Junji Konishi, MD1

1 Department of Nuclear Medicine and Diagnostic Imaging, Graduate School of Medicine, Kyoto University, Kyoto, Japan
2 Department of Diagnostic and Interventional Imagiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

The aim of this project was to study a mechanism that might explain the increased uptake of 18F-labeled FDG seen in inflammation. The approach chosen was to examine the effect on 18F-FDG uptake of acute activation of murine lymphocytes by concanavalin A (Con A). Methods: Immunocompetent BALB/c mice and nude mice received an intravenous injection of 10 mg/kg Con A. Twenty-four hours later, the mice received an intravenous injection of 0.74 MBq (20 µCi) 18F-FDG. One hour later, biodistribution was determined. The distribution of the radiolabel in the liver was also evaluated by autoradiography. In vitro 18F-FDG uptake to splenocytes from BALB/c mice with and without Con A pretreatment were determined 30, 60, and 120 min after the splenocytes were mixed with 18F-FDG (0.74 MBq [20 µCi]/200 µL). Results: In immunocompetent BALB/c mice, pretreatment with Con A significantly increased 18F-FDG uptake in the spleen and liver. Autoradiographs of the liver showed that pretreatment with Con A produced a specific localization of 18F-FDG at periportal areas, where numerous sites of cellular infiltration were observed. In vitro binding of 18F-FDG to the splenocytes was significantly higher for Con A-pretreated BALB/c mice than for control mice. Conclusion: This study showed that Con A increased 18F-FDG uptake. Con A-activated lymphocytes actively took up 18F-FDG both in vitro and in vivo, and 18F-FDG specifically accumulated in Con A-mediated acute inflammatory tissues.

Key Words: 18F-FDG PET • concanavalin A • lymphocyte • acute inflammation




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
T. Kalliokoski, P. Nuutila, K. A. Virtanen, P. Iozzo, M. Bucci, E. Svedstrom, A. Roivainen, K. Nagren, T. Viljanen, H. Minn, et al.
Pancreatic Glucose Uptake in Vivo in Men with Newly Diagnosed Type 1 Diabetes
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1909 - 1914.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Tahara, H. Kai, M. Ishibashi, H. Nakaura, H. Kaida, K. Baba, N. Hayabuchi, and T. Imaizumi
Simvastatin Attenuates Plaque Inflammation: Evaluation by Fluorodeoxyglucose Positron Emission Tomography
J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1825 - 1831.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
S. KAWAI, E. IKEDA, M. SUGIYAMA, J. MATSUMOTO, T. HIGUCHI, H. ZHANG, N. KHAN, K. TOMIYOSHI, T. INOUE, H. YAMAGUCHI, et al.
ENHANCEMENT OF SPLENIC GLUCOSE METABOLISM DURING ACUTE MALARIAL INFECTION: CORRELATION OF FINDINGS OF FDG-PET IMAGING WITH PATHOLOGICAL CHANGES IN A PRIMATE MODEL OF SEVERE HUMAN MALARIA.
Am J Trop Med Hyg, March 1, 2006; 74(3): 353 - 360.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. L. van Westreenen, D. C.P. Cobben, P. L. Jager, H. M. van Dullemen, J. Wesseling, P. H. Elsinga, and J. Th. Plukker
Comparison of 18F-FLT PET and 18F-FDG PET in Esophageal Cancer
J. Nucl. Med., March 1, 2005; 46(3): 400 - 404.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J.-J. Min, S. Biswal, C. Deroose, and S. S. Gambhir
Tetraphenylphosphonium as a Novel Molecular Probe for Imaging Tumors
J. Nucl. Med., April 1, 2004; 45(4): 636 - 643.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. Maschauer, O. Prante, M. Hoffmann, J. T. Deichen, and T. Kuwert
Characterization of 18F-FDG Uptake in Human Endothelial Cells In Vitro
J. Nucl. Med., March 1, 2004; 45(3): 455 - 460.
[Abstract] [Full Text]


Home page
Ann. Surg. Oncol.Home page
H. L. van Westreenen, P. A.M. Heeren, P. L. Jager, H. M. van Dullemen, H. Groen, and J. Th.M. Plukker
Pitfalls of Positive Findings in Staging Esophageal Cancer With F-18-Fluorodeoxyglucose Positron Emission Tomography
Ann. Surg. Oncol., November 1, 2003; 10(9): 1100 - 1105.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.